A recent analysis published in The Lancet using Global Burden of Disease 2023 data shows cancer has quietly risen into the top ten causes of death among children in India, highlighting a shifting disease burden as infectious illnesses fall and non‑communicable diseases gain ground. According to the Indian Council of Medical Research’s National Centre for Disease Informatics and Research (ICMR‑NCDIR), childhood cancers made up about 3–5% of all cancers in India in 2022, with an estimated 50,000–60,000 new cases annually among children aged 0–14. Globally, the Lancet paper reports roughly 377,000 new childhood cancer cases and 144,000 deaths in 2023.
Leukaemias (blood cancers) are the most common childhood cancers in India, followed by lymphomas and central nervous system tumours; together they account for the majority of paediatric cases. Incidence varies by region: urban registries such as Delhi report higher rates, a pattern experts attribute partly to better detection and reporting rather than true geographic clustering.
Specialists warn the documented figures understate the real burden. Incomplete cancer registration and limited diagnostic access, especially in rural and underserved areas, leave many cases unreported or diagnosed late. “A major driver of poor outcomes in India is delayed diagnosis,” an oncologist at Delhi State Cancer Institute said, noting that early symptoms-fever, fatigue, unexplained weight loss or swelling-often mimic common infections and are missed by caregivers and some primary‑care providers.
Because many children reach specialised centres only at advanced stages, treatment becomes more complex, costlier and less likely to succeed. Paediatric oncology services are concentrated in tertiary hospitals in large cities, forcing families from smaller towns and villages to travel long distances. Even when treatment is subsidised, indirect costs such as travel, accommodation and lost income can be overwhelming, contributing to treatment abandonment and poorer survival.
Survival outcomes are improving in India but remain uneven. While high‑income countries report childhood cancer survival above 80%, only select Indian centres of excellence report comparable results for cancers like acute lymphoblastic leukaemia. Nationwide gaps persist in long‑term follow‑up care for survivors, who may face late effects such as secondary cancers, organ damage or developmental problems.
The ICMR factsheet calls for a dedicated national approach: expanded population‑based cancer registries, specialised infrastructure, trained paediatric oncology teams and stronger referral systems to detect cancers earlier and reduce inequities in care and outcomes.
Original Source: https://www.indiatoday.in/health/story/childhood-cancer-india-leading-cause-death-delayed-diagnosis-2891077-2026-04-03
Category:
Tags:
Publish Date: 2026-04-03 13:25:00
